Idelalisib Active Not Recruiting Phase 2 Trials for Leukemia, Lymphocytic, Chronic, B-Cell / Chronic Lymphocytic Leukaemia (CLL) / Small Lymphocytic Lymphoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02639910Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi
NCT02968563Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
NCT02135133A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL